Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
8 tulemused
Compounds and method for protection of cells and tissues from irreversible injury due to lactic acidosis
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF INVENTION
Field of Invention
The present invention relates to compounds and to a method for protection of cells and tissues from irreversible injury due to lactic acidosis. More specifically, this invention relates to compounds permeable through the cell membrane and possessing a
Method for prevention and treatment of harmful effects of intracellular acidosis
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF INVENTION
1. Field of Invention
The present invention relates to a method for prevention and treatment of harmful effect of intracellular acidosis. The method protects cells and tissues from irreversible injury due to lactic acidosis. More specifically, this invention relates to method
Method for treating hypoxia-associated ocular complications
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
This invention generally relates to a method for the treatment of eye disorders. More specifically, it relates to a method and composition for preventing or treating hypoxia-associated ocular complications which employs at least two agents selected from the group consisting of
Imaging and targeting tumors using sickle cells
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention generally relates to the field of delivery vehicles for use in diagnostic and therapeutic applications, and specifically towards diagnostic and therapeutic applications involving hypoxic areas of a patient.
2. Description of
Intrauterine fetal growth restriction--the treatment modalities for clinical research, and the biochemical rationale
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
INTRODUCTION
This embodiment of invention is directed to novel treatments for `Intra Uterine Growth Restriction` (IUGR) of a human fetus, one of a long known and incurable (but treatable) maternal-fetoplacental pathology resulting significant mortality and morbidity of the fetus/neonate, it's
Intrauterine fetal growth restriction--the biochemical rationale of treatment modalities including extraperitoneal transamniotic fetal supplements
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The embodiment of this invention is directed to an exemplary and an innovative treatment involving `Intra Uterine Growth Restriction` (IUGR) of a human fetus, a long known and incurable but treatable maternal-fetoplacental pathology, resulting in significant mortality and morbidity of the
Adhesion prevention and an endoscopic insufflation system therefor
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention relates to adhesion prevention in general and to compounds, an endoscopic insufflation system and to a method for preventing adhesion formation in particular.
BACKGROUND OF THE INVENTION
Adhesion formation is a major problem following surgical procedures
Rationale for IL-1 .beta. targeted therapy to improve harvested organ viability, allograft tolerance, replant success and for conditions characterized by reduced or absent arterial perfusion
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
Ischemia-reperfusion injury (IRI) involving harvested organs and allograft transplantation may in part be caused by stimulation of a newly described innate pro-inflammatory immune system (i.e. cryopyrin-inflammasome, now referred to as NLRP-3 or NALP-3 inflammasome) that
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
